Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Human Reproduction (Oxford, England)|April 24, 2020
Ulipristal acetate and pregnancy outcome-an observational studyJenny Katharina Wagner, Katarina Dathe, Christof Schaefer, et al.
European Journal of Clinical Pharmacology|January 27, 2021
Ivabradine use in pregnant women-treatment indications and pregnancy outcome: an evaluation of the German Embryotox databaseMaria Hoeltzenbein, Marie-Louise Lehmann, Evelin Beck, et al.
Rheumatology (Oxford, England)|December 27, 2013
No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort studyCorinna Weber-Schoendorfer, Maria Hoeltzenbein, Evelin Wacker, et al.
Pharmacoepidemiology and Drug Safety|October 18, 2023
How to account for early overly small risk sets in the analysis of pregnancy outcome data?-Comparison of different methods for stabilizing the Aalen-Johansen estimatorRegina Stegherr, Anne-Katrin Fietz, Maria Hoeltzenbein, et al.
Scientific Reports|December 23, 2024
Trends in use of antiseizure medication and treatment pattern during the first trimester in the German Embryotox cohortMaria Hoeltzenbein, Sofia Slimi, Anne-Katrin Fietz, et al.
Reproductive Toxicology (Elmsford, N.Y.)|May 22, 2012
Pregnancy outcome after paternal exposure to azathioprine/6-mercaptopurineMaria Hoeltzenbein, Corinna Weber-Schoendorfer, Cornelia Borisch, et al.
Journal of Perinatal Medicine|September 17, 2024
Efficacy and safety of 2-drug regime dolutegravir/lamivudine in pregnancy and breastfeeding - clinical implications and perspectivesIrena Rohr, Maria Hoeltzenbein, Katharina Weizsäcker, et al.
Epilepsia|October 19, 2023
Antiepileptic treatment with levetiracetam during the first trimester and pregnancy outcome: An observational studyMaria Hoeltzenbein, Insa Bartz, Anne-Katrin Fietz, et al.
Pageof 4